Cargando…
EWS/FLI1 Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Ewing sarcoma is an aggressive bone malignancy that affect children and young adults. Ewing sarcoma is the second most common primary bone malignancy in pediatric patients. Although significant progress has been made in the treatment of Ewing sarcoma since it was first described in the 1920s, in the...
Autores principales: | Cidre-Aranaz, Florencia, Alonso, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507460/ https://www.ncbi.nlm.nih.gov/pubmed/26258070 http://dx.doi.org/10.3389/fonc.2015.00162 |
Ejemplares similares
-
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
por: Yasir, Muhammad, et al.
Publicado: (2023) -
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
por: Theisen, Emily R., et al.
Publicado: (2016) -
Lysyl Oxidase Is Downregulated by the EWS/FLI1 Oncoprotein and Its Propeptide Domain Displays Tumor Supressor Activities in Ewing Sarcoma Cells
por: Agra, Noelia, et al.
Publicado: (2013) -
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma
por: Gong, Helong, et al.
Publicado: (2023) -
The role of FLI-1-EWS, a fusion gene reciprocal to EWS-FLI-1, in Ewing sarcoma
por: Elzi, David J., et al.
Publicado: (2015)